The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.
Grote VA, Nieters A, Kaaks R, Tjønneland A, Roswall N, Overvad K, Nielsen MR, Clavel-Chapelon F, Boutron-Ruault MC, Racine A, Teucher B, Lukanova A, Boeing H, Drogan D, Trichopoulou A, Trichopoulos D, Lagiou P, Palli D, Sieri S, Tumino R, Vineis P, Mattiello A, Argüelles Suárez MV, Duell EJ, Sánchez MJ, Dorronsoro M, Huerta Castaño JM, Barricarte A, Jeurnink SM, Peeters PH, Sund M, Ye W, Regner S, Lindkvist B, Khaw KT, Wareham N, Allen NE, Crowe FL, Fedirko V, Jenab M, Romaguera D, Siddiq A, Bueno-de-Mesquita HB, Rohrmann S.
Grote VA, et al. Among authors: tjonneland a.
Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):619-28. doi: 10.1158/1055-9965.EPI-11-1139. Epub 2012 Feb 1.
Cancer Epidemiol Biomarkers Prev. 2012.
PMID: 22301828
Free article.